LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held February 11-12, 2025, at the Cliff Lodge in Snowbird, Utah. Management will hold one-on-one meetings throughout the conference.

About LifeMD, Inc.
LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com

Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare
AddThis Website Tools
Staff

Recent Posts

Promino Nutritional Sciences Inc. Announces that Promino(TM) Named Official Protein Drink of the Vegas Knight Hawks

Expanding U.S. sports presence as brand aligns with Las Vegas franchisesBurlington, Ontario--(Newsfile Corp. - April…

40 minutes ago

Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 17, 2025) - Medexus Pharmaceuticals (TSX: MDP)…

40 minutes ago

Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration

In the preliminary findings of a study conducted with the National Taiwan University Hospital, over…

8 hours ago

Spring Into Savings: VARON Offers Discounts on Oxygen Solutions for Allergy Season

NEW YORK, April 16, 2025 /PRNewswire/ -- As spring blooms across the country, so does allergy…

8 hours ago

Saudi Arabia and France Strengthen Health Cooperation Through Strategic Agreements in Biotech and Digital Health

PARIS, April 16, 2025 /PRNewswire/ -- On the second day of an official visit to…

8 hours ago

Beyond Medical Technologies Announces Filing of Application for Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - April 16, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT)…

12 hours ago